GLP-1 signals: fullness slower digestion lower cravings balanced blood sugar But cortisol interrupts: SCFA-driven GLP-1 release enteroendocrine signaling hormonal circadian timing gut barrier stability Low GLP-1 means more hunger, stronger cravings, and weaker appetite control
Newer drugs, such as tirzepatide, a dual GLP-1, and GIP receptor agonist, are quickly gaining traction and demonstrating encouraging outcomes in clinical trials for weight management. Other popular diabetes medications include metformin, gliflozins (Farxiga, Jardiance), and sulfonylureas (Glucotrol, Amaryl)
That being said, its commonly reported that patients who are new to taking GLP-1s may experience some injection site discomfort
Ideal pack size: Whether individually for on the go or as a stock supply the pack of 12 keeps you well prepared
Your doctor will check your health during your first visit